Article
Projected 2023 Cost Reduction From Tumor Necrosis Factor α Inhibitor Biosimilars in Dermatology: A National Medicare Analysis
- Author:
- Katie Roster, MD
- Christian Gronbeck, MD
- Hao Feng, MD, MHS
To the Editor:
Although biologics provide major therapeutic benefits for dermatologic conditions, they also come with a substantial cost,...